These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30794794)

  • 1. Innovation in Chemistry, Manufacturing, and Controls-A Regulatory Perspective From Industry.
    Cauchon NS; Oghamian S; Hassanpour S; Abernathy M
    J Pharm Sci; 2019 Jul; 108(7):2207-2237. PubMed ID: 30794794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging technology: A key enabler for modernizing pharmaceutical manufacturing and advancing product quality.
    O'Connor TF; Yu LX; Lee SL
    Int J Pharm; 2016 Jul; 509(1-2):492-498. PubMed ID: 27260134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDA Biosimilars Workshop Report (September 27-28, 2018)-Getting It Right the First Time for Biosimilar Marketing Applications.
    Krause S; Lacana E; Welch J; Shapiro M; Downey C; Chung J; Zhou Q; Van Der Plas M; Depatie C; Ingram B; Srebalus-Barnes C; Polozova A; Rellahan B; Choi D; Burdick R; Stangler T; Shacter E
    PDA J Pharm Sci Technol; 2019; 73(4):401-416. PubMed ID: 31004040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and establishment of specifications for biopharmaceuticals.
    Davis GC; Riggin RM
    Dev Biol Stand; 1997; 91():49-54. PubMed ID: 9413683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specifications from a biotechnology industry perspective.
    Garnick RL
    Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Taiwan's strategies for regulating nanotechnology-based pharmaceuticals harmonized with international considerations.
    Guo JW; Lee YH; Huang HW; Tzou MC; Wang YJ; Tsai JC
    Int J Nanomedicine; 2014; 9():4773-83. PubMed ID: 25342901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-Envisioning Pharmaceutical Manufacturing: Increasing Agility for Global Patient Access.
    Algorri M; Abernathy MJ; Cauchon NS; Christian TR; Lamm CF; Moore CMV
    J Pharm Sci; 2022 Mar; 111(3):593-607. PubMed ID: 34478754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovation in Regulatory Science Is Meeting Evolution of Clinical Evidence Generation.
    Lee M; Ly H; Möller CC; Ringel MS
    Clin Pharmacol Ther; 2019 Apr; 105(4):886-898. PubMed ID: 30636288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry Manufacturing and Controls Development, Industry Reflections on Manufacture, and Supply of Pandemic Therapies and Vaccines.
    Popkin ME; Goese M; Wilkinson D; Finnie S; Flanagan T; Campa C; Clinch A; Teasdale A; Lennard A; Cook G; Mohan G; Osborne MD
    AAPS J; 2022 Sep; 24(6):101. PubMed ID: 36168002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.
    Byrn S; Futran M; Thomas H; Jayjock E; Maron N; Meyer RF; Myerson AS; Thien MP; Trout BL
    J Pharm Sci; 2015 Mar; 104(3):792-802. PubMed ID: 25501530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Confluence of Innovation in Therapeutics and Regulation: Recent CMC Considerations.
    Gutierrez L; Cauchon NS; Christian TR; Giffin MJ; Abernathy MJ
    J Pharm Sci; 2020 Dec; 109(12):3524-3534. PubMed ID: 32971125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Srai JS; Badman C; Krumme M; Futran M; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the evolution of the pharmaceutical regulatory environment.
    Shafiei N; Ford JL; Morecroft CW; Lisboa PJ; Taylor MJ
    PDA J Pharm Sci Technol; 2013; 67(4):297-306. PubMed ID: 23872441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provable Data Integrity in the Pharmaceutical Industry Based on Version Control Systems and the Blockchain.
    Steinwandter V; Herwig C
    PDA J Pharm Sci Technol; 2019; 73(4):373-390. PubMed ID: 30770485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Applications and Regulatory Strategies for Advanced Medicines Manufacturing - Towards the Development of a Platform Approach.
    Srai JS; Bauer P; Badman C; Bresciani M; Cooney CL; Florence A; Hausner D; Konstantinov K; Lee SL; Mascia S; Nasr M; Trout BL
    J Pharm Sci; 2024 Jul; 113(7):1701-1710. PubMed ID: 38663498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations for the chemistry, manufacturing and Controls (CMC) - quality package for COVID-19 vaccines- interim lessons learnt by the European medicines Agency (EMA).
    Shivji R; Conocchia R; Korakianiti E; Jekerle V
    Vaccine; 2022 Sep; 40(38):5539-5541. PubMed ID: 35779964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.